Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Experimental Peptide Creates Risk for Athletes Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps